BioLineRx Ltd. (BLRX)
2.29
+0.01
(+0.44%)
USD |
NASDAQ |
Apr 10, 16:00
BioLineRx EPS Diluted (Quarterly) : -0.32 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Compugen Ltd. | 0.6002 |
| Pluri, Inc. | -0.7066 |
| XTL Biopharmaceuticals Ltd. | -0.1169 |
| Can-Fite BioPharma Ltd. | -- |
| Evogene Ltd. | -0.609 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.25M |
| Revenue (Quarterly) | 0.1952M |
| Total Expenses (Quarterly) | 1.589M |
| Enterprise Value | 4.388M |
| Gross Profit Margin (Quarterly) | 46.93% |
| Profit Margin (Quarterly) | -1.15K% |
| Earnings Yield | -7.90% |
| Normalized Earnings Yield | -8.066 |